Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update May 7, 2024 08:00AM
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update Mar 12, 2024 08:00AM
Corbus Pharma (CRBP) Appoints Dr. Dominic Smethurst as Chief Medical Officer Feb 28, 2024 08:01AM
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer Feb 28, 2024 08:00AM
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director Oct 19, 2023 04:00AM


Oct 4, 2023 07:00AM Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercialization
May 10, 2023 08:03AM Bicycle Therapeutics (BCYC) and Bayer Collaborate for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023 08:00AM Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023 07:07AM Bayer and Bicycle Therapeutics (BCYC) Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023 07:00AM Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Apr 26, 2023 04:00AM NRG Therapeutics Appoints Dr Jonathan Savidge as Independent Chair
Mar 2, 2022 02:00AM BioMed Realty Leases 96,000 Square Feet at the Company’s Flagship Granta Park Campus in Cambridge
Dec 10, 2021 08:00PM Annual Changes to the Nasdaq Biotechnology Index
Nov 4, 2021 03:00AM OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins
Nov 3, 2021 07:00AM Ionis reports third quarter 2021 financial results and recent business achievements
Aug 4, 2021 07:00AM Ionis reports second quarter 2021 financial results and recent business achievements
Jul 13, 2021 06:59AM Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology
Jul 13, 2021 06:59AM Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
Apr 15, 2021 07:00AM Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors
Jun 22, 2020 07:00AM Annual results for the year ended 31 March 2020
Jun 9, 2020 08:00AM Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage
Dec 2, 2019 07:00AM Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies
Oct 16, 2019 04:33PM Bicycle Therapeutics to Present New Translational Data for BT1718 and Preclinical Data for Other Bicycle® Toxin Conjugates at AACR-NCI-EORTC 2019
Sep 28, 2019 06:00AM Bicycle Therapeutics Announces Presentation of Updated Data from Phase I/IIa Trial Evaluating BT1718 in Patients with Advanced Solid Tumors at ESMO 2019 Annual Congress
Aug 1, 2019 07:00AM Bicycle Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
Jul 24, 2019 08:05AM Bicycle Therapeutics Plc (BCYC) Announces Richard N. Kender and Janice Bourque to Board
Jul 24, 2019 08:00AM Bicycle Therapeutics Enhances Board of Directors
Jul 1, 2019 07:31AM Bicycle Therapeutics Plc (BCYC) Announces Positive Topline Results from Oxurion's Phase I Trial Using Novel Bicycle-based Plasma Kallikrein Inhibitor for Treatment of DME
Jul 1, 2019 07:30AM Bicycle Therapeutics Announces Positive Topline Results from Oxurion’s Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema
Jun 21, 2019 07:00AM Annual results for the year ended 31 March 2019
May 29, 2019 05:04AM Citi Appointed as Depositary Bank for Bicycle Therapeutics’ ADR Programme